Salk researchers found that a drug already approved by the FDA for the treatment of psoriasis deactivates the switch governing
the fibrotic response in mouse liver cells, suggesting a potential new therapy for fibrotic diseases in humans.
This is important because many different pro-fibrotic signaling pathways converge on the genome to affect
their fibrotic response.»
The Salk discovery that calcipotriol counters
the fibrotic response in stellate cells illuminates a potentially safer, more effective strategy capable of neutralizing multiple convergent fibrotic triggers.
Now, in a new study published in the journal Cell, scientists at the Salk Institute for Biological Studies have discovered that a synthetic form of vitamin D, calcipotriol (a drug already approved by the FDA for the treatment of psoriasis), deactivates the switch governing
the fibrotic response in mouse liver cells, suggesting a potential new therapy for fibrotic diseases in humans.
Not exact matches
Mesenchymal stem cell engraftment in lung is enhanced in
response to bleomycin exposure and ameliorates its
fibrotic effects.